MiR-205 suppresses tumor growth, invasion, and epithelial-mesenchymal transition by targeting SEMA4C in hepatocellular carcinoma

被引:25
作者
Lu, Jiong [1 ]
Lin, Yixin [1 ]
Li, Fuyu [1 ]
Ye, Hui [1 ]
Zhou, Rongxing [1 ]
Jin, Yanwen [1 ]
Li, Bei [1 ]
Xiong, Xianze [1 ]
Cheng, Nansheng [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Bile Duct Surg, 37 Guo Xue Xiang Rd, Chengdu 610041, Sichuan, Peoples R China
关键词
microRNA; EMT; SEMA4C; HCC; CELL-PROLIFERATION; CANCER CELLS; DOWN-REGULATION; BREAST-CANCER; METASTASIS; EXPRESSION; MICRORNA-205; PROGRESSION; PATHWAY; ZEB1;
D O I
10.1096/fj.201800113R
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Growing evidence indicates that microRNAs are involved in tumorigenesis and progression of hepatocellular carcinoma (HCC). However, the functional mechanisms of miR-205 in HCC remain largely unknown. Here, we demonstrate that miR-205 expression was significantly down-regulated in HCC tissues and cell lines and was correlated with metastatic pathologic features and shorter disease-free and overall survival. Overexpression of miR-205 dramatically inhibited HCC cell proliferation, apoptosis, migration, invasion, epithelial-mesenchymal transition (EMT) in vitro, and tumor growth in vivo. We subsequently identified semaphorin 4C (SEMA4C) as a novel target of miR-205. Furthermore, high expression levels of SEMA4C were frequently found in HCC tissues and were associated with poor prognosis. Ectopic expression of SEMA4C restored the suppressive effect of overexpressed miR-205 on migration, invasion, and EMT. Taken together, our findings provide new insight into the critical role of miR-205 in regulating tumor growth, invasion, and EMT of HCC, suggesting miR-205 may serve as a promising therapeutic target and novel prognostic indicator for patients with HCC.Lu, J., Lin, Y., Li, F., Ye, H., Zhou, R., Jin, Y., Li, B., Xiong, X., Cheng, N. MiR-205 suppresses tumor growth, invasion, and epithelial-mesenchymal transition by targeting SEMA4C in hepatocellular carcinoma.
引用
收藏
页码:6123 / 6134
页数:12
相关论文
共 38 条
[1]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[2]   Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205 [J].
Chaudhary, Amit Kumar ;
Mondal, Goutam ;
Kumar, Virender ;
Kattel, Krishna ;
Mahato, Ram I. .
CANCER LETTERS, 2017, 402 :1-8
[3]   Regulatory networks defining EMT during cancer initiation and progression [J].
De Craene, Bram ;
Berx, Geert .
NATURE REVIEWS CANCER, 2013, 13 (02) :97-110
[4]   miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4 [J].
Dou, Changwei ;
Liu, Zhikui ;
Xu, Meng ;
Jia, Yuli ;
Wang, Yufeng ;
Li, Qing ;
Yang, Wei ;
Zheng, Xin ;
Tu, Kangsheng ;
Liu, Qingguang .
CANCER LETTERS, 2016, 381 (02) :380-390
[5]   Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis [J].
El-Serag, Hashem B. ;
Rudolph, Lenhard .
GASTROENTEROLOGY, 2007, 132 (07) :2557-2576
[6]   MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma [J].
Fang, Feng ;
Chang, Rui-min ;
Yu, Lei ;
Lei, Xiong ;
Xiao, Shuai ;
Yang, Hao ;
Yang, Lian-Yue .
JOURNAL OF HEPATOLOGY, 2015, 63 (04) :874-885
[7]   Hepatocellular carcinoma [J].
Forner, Alejandro ;
Llovet, Josep M. ;
Bruix, Jordi .
LANCET, 2012, 379 (9822) :1245-1255
[8]   MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway [J].
Fu, Xiao ;
Wen, Hongqing ;
Jing, Li ;
Yang, Yujuan ;
Wang, Wenjuan ;
Liang, Xuan ;
Nan, Kejun ;
Yao, Yu ;
Tian, Tao .
CANCER SCIENCE, 2017, 108 (04) :620-631
[9]   Targeting the HGF/c-MET Pathway in Hepatocellular Carcinoma [J].
Goyal, Lipika ;
Muzumdar, Mandar D. ;
Zhu, Andrew X. .
CLINICAL CANCER RESEARCH, 2013, 19 (09) :2310-2318
[10]   Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells [J].
He, Jialin ;
Zhao, Kai ;
Zheng, Lu ;
Xu, Zhizhen ;
Gong, Wei ;
Chen, Shan ;
Shen, Xiaodong ;
Huang, Gang ;
Gao, Min ;
Zeng, Yijun ;
Zhang, Yan ;
He, Fengtian .
MOLECULAR CANCER, 2015, 14